With the advent of technology, automation is now possible in multiplex testing, in addition to activities like microplate automation. Newborn screening is another field where extensive use of automation combined with software packages to identify complex metabolites is employed. In this immensely competitive world, squeezing the maximum efficiency out of every department, including the R & D labs, is a constant issue.
Automation of routine laboratory procedures, by the use of dedicated work stations and software to program instruments, allows associate scientists and technicians to think creatively about implications of their experimentation and to design effective follow-up projects or develop alternative approaches to their work instead of spending their days performing tasks of tedious repetition.
Clinical diagnostics involves testing a wide variety of samples ranging from blood to DNA. This requires a significant level of automation in order to achieve the required results consistently. Multiplex testing is the norm of the hour with an emphasis being laid on increasing the number of assays analyzed per unit time.
Apart from the reduction of mundane and tedious tasks, the market is also driven by the need for consistent quality as the cost of an error is very high, in a scientific paper or developing a drug. Even fairly low error rates can have a profound impact on the conclusions you make. By taking out the human element, more consistency is achieved. Great advances have been made in the molding of plastics thereby, enabling handling of smaller liquid volumes, which have also reduced the volumes of reagents being used and development of micro and nano-litre plates to fit in with the automated liquid handling equipment.
Major points in modern life science are validation and data quality; legal validation, patents and clinical testing have become crucial issues. Automation enables a much higher reproducibility, better documentation of data, and allows the production of more data points with great ease. It also ensures the safety of personnel in the presence of infectious or potentially hazardous material.
Automation has a wide variety of life sciences applications ranging from proteomics to systems biology. High throughput is the core driving factor in clinical diagnostics where profits are driven by the number of samples. Total automation is generally preferred in such labs and manufacturing setups. Research labs and academic institutions are generally opting for modular automation wherein, they reduce human intervention in tedious and repetitive tasks but still involve manually in a considerable number of tasks.
North America is the clear market leader with around 60% of market share followed by Europe. Asia and Latin America are emerging as there is a considerable increase in the outsourcing of pharmaceutical manufacturing to these regions due to the availability of cheaper labor and resources. Automation is the most prevalent in the diagnostics market followed by the discovery and research labs.
The report analyzes the market across various geographies with the key trends in each region. It provides the market share and profiles of the top companies involved in lab automation with insights on how the market will vary within the next five years and how the companies are strategically planning.
Key Deliverables in the Study